Shunyou Gong

Dr. Shunyou Gong


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2005 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
KNKim E Nichols
Kim E Nichols
JHJamie Hom
Jamie Hom
Shunyou GongShunyou Gong
Shunyou Gong
AGArupa Ganguly
Arupa Ganguly
CMCindy S Ma
Cindy S Ma
PSPaul L Stein
Paul L Stein

1 May 2008 in Cell
Verified
Journal Article
Closed access
HSHonghong Sun
Honghong Sun
Shunyou GongShunyou Gong
Shunyou Gong
RCRuaidhri J. Carmody
Ruaidhri J. Carmody
AHAnja Hilliard
Anja Hilliard
LLLi Li
Li Li
YCYouhai H. Chen
Youhai H. Chen

25 August 2016 in Blood
Verified
Journal Article
Open access
PDF file
JSJanine Schmidt
Janine Schmidt
Shunyou GongShunyou Gong
Shunyou Gong
Teresa MarafiotiTeresa Marafioti
Teresa Marafioti
BMBarbara Mankel
Barbara Mankel
BGBlanca Gonzalez-Farre
Blanca Gonzalez-Farre
LQLeticia Quintanilla-Fend
Leticia Quintanilla-Fend
Key Points: PTFL is a monoclonal B-cell neoplasia with low genomic complexity and recurrent TNFRSF14 mutations/deletions. The genetic profiles of conventional t(14;18)− and t(14;18)+ FL are similar but distinct from PTFL.

7 July 2003 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
EBEdward M. Behrens
Edward M. Behrens
PGPaul Gadue
Paul Gadue
Shunyou GongShunyou Gong
Shunyou Gong
SGStacey Garrett
Stacey Garrett
PSPaul L. Stein
Paul L. Stein
PCPhilip L. Cohen
Philip L. Cohen
The mer receptor tyrosine kinase mediates phagocytosis of apoptotic cells and modulates cytokine production; it is also required for prevention of systemic autoimmune disease. Using a mer‐specific antibody, we have confirmed the presence of mer on macrophages and now report its expression on NK cells, NKT cells, and dendritic cells (DC). We found that DC do not require mer for ingestion of apoptotic cells, as DC from mer‐deficient mice phagocytose apoptotic cells normally. Mer was observed in splenic sections on cells outside follicular areas, probably representing DC and macrophages. Mer apparentlyparticipates in NKT‐cell antigen‐induced signaling, as NKT cells from mer‐deficient mice evinced much lower cytokine production after in vivo α‐galactosylceramide stimulation; this defect was intrinsic to the mer‐deficient NKT cells. Taken together, these studies show mer expression on cells of the innate immune system. Mer, through its binding of lipid antigens, may not only mediate ingestion of apoptotic cells, but also signal events in NK cells, NKT cells, and DC.

14 December 2008 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
XZXu Zhang
Xu Zhang
JWJiawei Wang
Jiawei Wang
CFChao Fan
Chao Fan
HLHubo Li
Hubo Li
HSHonghong Sun
Honghong Sun
YSYigong Shi
Yigong Shi

1 June 2009 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MLMaciej W. Ludwinski
Maciej W. Ludwinski
JSJing Sun
Jing Sun
BHBrendan Anthony Hilliard
Brendan Anthony Hilliard
Shunyou GongShunyou Gong
Shunyou Gong
FXFan Xue
Fan Xue
YCYouhai H. Chen
Youhai H. Chen
Bim, the B cell lymphoma 2–interacting (Bcl2-interacting) mediator, maintains immunological tolerance by deleting autoreactive lymphocytes through apoptosis. We report here that Bim is also, paradoxically, required for the activation of autoreactive T cells. Deletion of Bim in hematopoietic cells rendered mice resistant to autoimmune encephalomyelitis and diabetes, and Bim-deficient T cells had diminished cytokine production. Upon T cell receptor activation, Bim-deficient T cells exhibited severe defects in both calcium release and dephosphorylation of nuclear factor of activated T cells (NFAT) but maintained normal levels of activation of NF-κB and MAPKs. The defective calcium signaling in Bim-deficient T cells was associated with a significant increase in the formation of an inhibitory complex containing Bcl2 and the inositol triphosphate receptor (IP3R). Thus, in addition to mediating the death of autoreactive T cells, Bim also controlled T cell activation through the IP3R/calcium/NFAT pathway. These results indicate that a single protein is used to control both the activation and apoptosis of autoreactive T cells and may explain why Bim-deficient mice do not reject their own organs despite lacking thymic negative selection.